Leaders' Update 
A message from Donna Berrier, M.P.A., chief administrative officer
Massey recently submitted its yearly Cancer Center Support Grant (CCSG) progress report, which details significant Center accomplishments that are helping to grow our research enterprise and accomplish our mission of developing new ways to prevent, detect, treat and, ultimately, cure cancer.
This message continues with:
|
Research Highlights
|
 |
Cancer Cell Signaling
member |
Researchers uncover allergy-cancer connection
A new study demonstrated that histamine induces the activation, survival and proliferation of myeloid derived suppressor cells (MDSCs), which help promote tumor growth by suppressing the immune system. By blocking the production of histamine in animal models, the researchers were able to interrupt a process that promotes melanoma growth.
|
Scientists pinpoint protein that could improve small cell lung cancer therapies
Researchers discovered that the expression of a protein called Noxa is critical to the effectiveness of the drug ABT-737 because it helps regulate the function of MCL-1, a pro-survival Bcl-2 family protein.
|
Center News
|
Arthur awarded endowed chair
Douglas Arthur, M.D., has been awarded the Natalie N. and John R. Congdon, Sr. Endowed Chair in Cancer Research.
|
Member Showcase
Reed develops nanoscale measurement approaches to understand growth properties of cancer
Jason Reed, Ph.D., Massey research member, applies imaging approaches to look at how cancer cells grow or how they respond to treatment.
|
Researcher Recognition
|
Massey researchers awarded over $800,000 in grant funding
Congratulations to the following Massey members who were awarded funding:
|
|
